Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06719193Phase 2Recruiting

DeMONSTRATE-TB Study in Ethiopia

Role: lead

NCT04709302Unknown

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa

Role: collaborator

NCT03376217Not ApplicableCompleted

Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi

Role: collaborator

NCT02005835Not ApplicableUnknown

Promoting Uptake and Retention of Option B+ in Malawi

Role: collaborator

All 4 trials loaded